dc.contributor.author | ANTWI-BOASIAKO, C. | |
dc.contributor.author | FRIMPONG, E. | |
dc.contributor.author | ABABIO, G. K. | |
dc.contributor.author | DZUDZOR2, B. | |
dc.contributor.author | EKEM, I. | |
dc.contributor.author | ANTWI, D. A. | |
dc.contributor.author | SODZI-TETTEY, N.A | |
dc.date.accessioned | 2021-03-26T10:45:34Z | |
dc.date.available | 2021-03-26T10:45:34Z | |
dc.date.issued | 2015-06 | |
dc.identifier.uri | http://hdl.handle.net/123456789/5184 | |
dc.description.abstract | Background: Foetal haemoglobin has been implicated in the modulation of sickle cell crisis. Its level is generally inversely proportional to the severity of sickle cell disease (SCD) for a given sickle cell phenotypes. The main aim of therapy for vaso-occlusive crisis (VOC), which is the hallmark of SCD, is to reduce the chances of sickling through the prevention of polymerization of HbS. One way of preventing this polymerization is by increasing foetal haemoglobin levels. | en_US |
dc.language.iso | en | en_US |
dc.subject | Haemoglobin F | en_US |
dc.subject | Frequency of crisis | en_US |
dc.subject | sickle cell disease | en_US |
dc.title | SICKLE CELL DISEASE: REAPPRAISAL OF THE ROLE OF FOETAL HAEMOGLOBIN LEVELS IN THE FREQUENCY OF VASO-OCCLUSIVE CRISIS | en_US |
dc.type | Article | en_US |